Thursday 9 July 2020
Home      All news      Contact us     
wn.com - 9 days ago

Gilead Prices COVID-19 Drug At $2,340 Per Patient In Developed Nations

Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed to send nearly all of its supply of the drug to the United States over the... ......


Latest News
Hashtags:   

Gilead

 | 

Prices

 | 

COVID

 | 

Patient

 | 

Developed

 | 

Nations

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources